METAP2 and colorectal carcinoma: Relative to DMSO-only treated cells, knockdown of METAP1 or METAP2 in fluorescent pTREBAV-miR-E-transduced CRC and HCC cells depleted the knockdown cells in the population only to minor extent (mostly < 20%).